Shenzhen Profound View Pharmaceutical Technology Co., Ltd. was founded in 2017, located in Nanshan District, Shenzhen, and is a registered small and medium-sized enterprise of science and technology in Shenzhen. Relying on deep see investment fund company in Beijing early nano drug research charity founded the vc project, after famous investment institutions black-necked cranes fund management co., LTD., an angel round (the black-necked crane fund management co., LTD. : tencent music angel, an angel investment, after six years of development, the success of landing the nyse board, market value of nearly 200 billion).
       At the present stage, the company's main research direction is the research and development of new drugs for neurodegenerative diseases 1.1. In April 2018, the company established the Wuhan R&d and production base -- Wuhan Guangxing Science And Research Knight Company, which is located in the Optical Valley International Biomedical Industrial Park in Wuhan. The laboratory covering more than 1,300 square meters has been completed and put into use. The company has a professional team integrating research and development, production and quality management, introducing domestic advanced production technology and equipment, and taking one of the new drugs of neurodegenerative disease series independently researched and developed as the access point of research and development application, gradually extending other series of projects.
       Our scientific research cooperation units include Wuhan University of Technology, German Research Center for Neurodegenerative Diseases, University of Toronto, Canada, Academy of Military Medical Sciences, Wuhan Institute of Virology, Chinese Academy of Sciences, Yao Ming Kde, etc. The long-term development plan is to build an open scientific research platform integrating capital, university and research under the win-win framework of enterprises, governments, universities and venture capital institutions, and to build unique scientific research entities such as Stanford Research Institute or Bell Laboratory.